1.
Neurofibromatosis type 2
by Asthagiri, Ashok R, Dr
The Lancet (British edition), 2009, Vol.373 (9679), p.1974-1986
2.
Germ-line mutations in the neurofibromatosis 2 gene : Correlations with disease severity and retinal abnormalities
by PARRY, D. M
American journal of human genetics, 1996, Vol.59 (3), p.529-539
3.
Clinical and molecular predictors of mortality in neurofibromatosis 2: a UK national analysis of 1192 patients
by Hexter, Adam
Journal of Medical Genetics, 2015, Vol.52 (10), p.699-705
4.
Functional Analysis of the Neurofibromatosis Type 2 Protein by Means of Disease-Causing Point Mutations
by Stokowski, Renee P
American journal of human genetics, 2000, Vol.66 (3), p.873-891
5.
Bilateral vestibular schwannomas in older patients: NF2 or chance?
by Evans, D G
Journal of medical genetics, 2015, Vol.52 (6), p.422-424
6.
Cranial meningiomas in 411 neurofibromatosis type 2 (NF2) patients with proven gene mutations: clear positional effect of mutations, but absence of female severity effect on age at...
by Smith, Miriam J
Journal of medical genetics, 2011, Vol.48 (4), p.261-265
7.
Empirical development of improved diagnostic criteria for neurofibromatosis 2
by Baser, Michael E.
Genetics in medicine, 2011, Vol.13 (6), p.576-581
8.
Neurofibromatosis 2 [Bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II]
by Evans, D Gareth R
Genetics in medicine, 2009, Vol.11 (9), p.599-610
9.
Multiple synchronous sites of origin of vestibular schwannomas in neurofibromatosis Type 2
by Stivaros, Stavros M
Journal of medical genetics, 2015, Vol.52 (8), p.557-562
10.
Natural history of neurofibromatosis type 2 with onset before the age of 1 year
by Ruggieri, Martino
Neurogenetics, 2013, Vol.14 (2), p.89-98
11.
Mosaicism in neurofibromatosis type 2: an update of risk based on uni/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including multiple ligat...
by Evans, D Gareth R
Journal of medical genetics, 2007, Vol.44 (7), p.424-428
12.
Neurofibromatosis type 2 (NF2): diagnosis and management
by EVANS, GARETH
Peripheral Nerve Disorders, 2013, p.957-967
13.
Mutational analysis of patients with neurofibromatosis 2
by MACCOLLIN, M
American journal of human genetics, 1994, Vol.55 (2), p.314-320
14.
Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas
by DEPREZ, R. H. L
American journal of human genetics, 1994, Vol.54 (6), p.1022-1029
15.
Intracranial meningiomas and neurofibromatosis type 2
by Aboukais, Rabih
Acta neurochirurgica, 2013, Vol.155 (6), p.997-1001
16.
Von Recklinghausen's neurofibromatosis: neurofibromatosis type 1
by Reynolds, RM
The Lancet (British edition), 2003, Vol.361 (9368), p.1552-1554
17.
Age at Diagnosis of Pheochromocytoma Differs According to Catecholamine Phenotype and Tumor Location
by Eisenhofer, Graeme
The journal of clinical endocrinology and metabolism, 2011, Vol.96 (2), p.375-384
18.
Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors
by Ng, H K
Neurosurgery, 1995, Vol.37 (4), p.764-773
19.
Genotype-Phenotype Correlations for Nervous System Tumors in Neurofibromatosis 2: A Population-Based Study
by Baser, Michael E
American journal of human genetics, 2004, Vol.75 (2), p.231-239
20.
Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas
by Kluwe, L
Journal of medical genetics, 2003, Vol.40 (2), p.109-114
